Publication | Open Access
Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial. Diabetes Care 2013;36:2508–2515
93
Citations
0
References
2013
Year
Metabolic SyndromeCare 2013Diabetes ManagementCardiovascular DiseaseDiabetesType 2PharmacotherapyDiabetes MellitusMedicineAnticoagulant52-Week Randomized Trial
Canagliflozin compared with sitagliptin for patients with type 2 diabetes who